Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119132) titled 'The median effective dose of Tegileridine when combined with ciprofol for hysteroscopy' on Feb. 24.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The People's Hospital of Suzhou Gaoxin District
Condition:
Hysteroscopy
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-05
Target Sample Size: Intervention group:40;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=309576
Published by HT Digital Content Services with permission from Health Daily Digest....